News

ESTEVE signs a licensing agreement for a severe primary insulin-like growth factor 1 deficiency treatment
ESTEVE has signed a license and supply agreement with Eton Pharmaceuticals with global rights for Increlex®, except for USA.
Nature3mon
How safe is growth hormone therapy for children?
the risk of a second neoplasm is increased in children with hypopituitarism ... of adverse events or whether monitoring of insulin-like growth factor 1 levels during treatment, as recommended ...
News-Medical.Net on MSN7d
Gut bacteria and blood metabolites directly affect children’s height, study finds
Researchers used Mendelian randomization to uncover causal links between gut microbiota, blood metabolites, and short stature ...
Hosted on MSN1mon
Experts warn poor nutrition puts children at risk of cancer. Here's what parents need to know
The immune system is weaker in undernourished children, and they are likely ... Low-calorie diets can interfere with insulin-like growth factor (IGF-1) signaling, which is involved in cell ...
Nature27d
Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides
Stimulation of epidermal keratinocytes by insulin-like growth factor I (IGF-I ... after approval by the Royal Children's Hospital Ethics in Human Research Committee. A portion of each specimen ...